United Therapeutics Corporation shares owned by New England Research & Management
Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by New England Research & Management
from 13F filings
Historical chart of New England Research & Management investment in United Therapeutics Corporation
Tip: Access up to 7 years of quarterly data
All positions including United Therapeutics Corporation held by New England Research & Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in United Therapeutics Corporation by New England Research & Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.4M | 10k | 229.72 |
| 2023-12-31 | $1.8M | 8.0k | 219.91 |
| 2023-09-30 | $1.9M | 8.5k | 225.87 |
| 2023-06-30 | $1.4M | 6.3k | 220.70 |
| 2023-03-31 | $1.2M | 5.6k | 223.90 |
| 2022-12-31 | $1.2M | 4.5k | 278.20 |
| 2022-09-30 | $1.2M | 5.6k | 209.37 |
| 2021-12-31 | $1.0M | 4.7k | 216.04 |
| 2021-09-30 | $1.0M | 5.5k | 184.59 |
| 2021-06-30 | $202k | 1.1k | 179.56 |
| 2021-03-31 | $544k | 3.3k | 167.38 |
More positions owned by New England Research & Management
View all positions for New England Research & Management
Top funds holding United Therapeutics Corporation
View all funds holding United Therapeutics Corporation